These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Rothman N; Stewart WF; Schulte PA Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):301-11. PubMed ID: 7655323 [TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology of physical activity and cancer. Rundle A Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):227-36. PubMed ID: 15668499 [TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology: new rules for new tools? Merlo DF; Sormani MP; Bruzzi P Mutat Res; 2006 Aug; 600(1-2):3-11. PubMed ID: 16843503 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers in cancer epidemiology: an integrative approach. Boffetta P Carcinogenesis; 2010 Jan; 31(1):121-6. PubMed ID: 19959558 [TBL] [Abstract][Full Text] [Related]
6. Impacts of chemicals on liver cancer risk. Wogan GN Semin Cancer Biol; 2000 Jun; 10(3):201-10. PubMed ID: 10936069 [TBL] [Abstract][Full Text] [Related]
7. Biomarkers in aquatic plants: selection and utility. Brain RA; Cedergreen N Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039 [TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology: a tool for understanding mechanisms of disease. Boffetta P Eur J Surg Suppl; 2002; (587):62-9. PubMed ID: 16144203 [TBL] [Abstract][Full Text] [Related]
11. Biomarkers in terrestrial invertebrates for ecotoxicological soil risk assessment. Kammenga JE; Dallinger R; Donker MH; Köhler HR; Simonsen V; Triebskorn R; Weeks JM Rev Environ Contam Toxicol; 2000; 164():93-147. PubMed ID: 12587835 [TBL] [Abstract][Full Text] [Related]
12. The use of biological markers as predictive early-outcome measures in epidemiological research. McMichael AJ; Hall AJ IARC Sci Publ; 1997; (142):281-9. PubMed ID: 9354927 [TBL] [Abstract][Full Text] [Related]
13. Selection and validation of biomarkers for chemoprevention: the contribution of epidemiology. Vineis P; Veglia F IARC Sci Publ; 2001; 154():57-68. PubMed ID: 11220669 [TBL] [Abstract][Full Text] [Related]
14. Effects of biomarker measurement error on epidemiological studies. White E IARC Sci Publ; 1997; (142):73-93. PubMed ID: 9354913 [TBL] [Abstract][Full Text] [Related]
15. Carcinogen-DNA adducts as a biomarker for cancer risk. Rundle A Mutat Res; 2006 Aug; 600(1-2):23-36. PubMed ID: 16824556 [TBL] [Abstract][Full Text] [Related]
16. Sources of variation in biomarkers. Vineis P IARC Sci Publ; 1997; (142):59-71. PubMed ID: 9354912 [TBL] [Abstract][Full Text] [Related]
17. Strategic issues in the design and interpretation of studies on metabolic polymorphisms and cancer. Vineis P; Malats N IARC Sci Publ; 1999; (148):51-61. PubMed ID: 10493248 [TBL] [Abstract][Full Text] [Related]
18. Mechanistic insights from biomarker studies: somatic mutations and rodent/human comparisons following exposure to a potential carcinogen. Albertini RJ IARC Sci Publ; 2004; (157):153-77. PubMed ID: 15055295 [TBL] [Abstract][Full Text] [Related]
19. Identification and application of biomarkers in molecular and genomic epidemiologic research. Lee KM; Han S; Park WY; Kang D J Prev Med Public Health; 2009 Nov; 42(6):349-55. PubMed ID: 20009480 [TBL] [Abstract][Full Text] [Related]